Evidence map›Paper›PMID 30724698›Full record

ArticleCell cycle (Georgetown, Tex.)2019

The role of PAK1 in the sensitivity of kidney epithelial cells to ischemia-like conditions.

Evan R Zynda, Mitchell H Maloy, Eugene S Kandel

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Evan R Zyndaa Department of Cell Stress Biology , Roswell Park Comprehensive Cancer Center , Buffalo , NY , USA.
Mitchell H Maloya Department of Cell Stress Biology , Roswell Park Comprehensive Cancer Center , Buffalo , NY , USA.
Eugene S Kandela Department of Cell Stress Biology , Roswell Park Comprehensive Cancer Center , Buffalo , NY , USA.
Roswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI CANDACE S JOHNSON · 1985 to 2026
$116.6M
Summer Research Experiences in Quantitative Cancer Sciences and Emerging TechnologiesR25CA181003 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI PAMELA A HERSHBERGER, Mukund Seshadri · 2014 to 2026
$3.3M
Genes determining sensitivity to oxygen and nutrient deprivationR03CA205178 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI KANDEL, EUGENE S · 2017 to 2018
$174k
NCI NIH HHS P30 CA016056NCI NIH HHS R03 CA205178NCI NIH HHS R25 CA181003
6 · The paper itself

Abstract

Kidney ischemia, characterized by insufficient supply of oxygen and nutrients to renal epithelial cells, is the main cause of acute kidney injury and an important contributor to mortality world-wide. Earlier research implicated a G-protein coupled receptor (NK1R) in the death of kidney epithelial cells in ischemia-like conditions. P21-associated kinase 1 (PAK1) is involved in signalling by several G-proteins. We explored the consequences of PAK1 inhibition for cell survival under the conditions of reduced glucose and oxygen. Inhibition of PAK1 by RNA interference, expression of a dominant-negative mutant or treatment with small molecule inhibitors greatly reduced the death of cultured kidney epithelial cells. Similar protection was achieved by treating the cells with inhibitors of MEK1, in agreement with the prior reports on PAK1-MEK1 connection. Concomitant inhibition of NK1R and PAK1 offered no better protection than inhibition of NK1R alone, consistent with the two proteins being members of the same pathway. Furthermore, NK1R, PAK and MEK inhibitors reduced the induction of TRAIL in ischemia-like conditions. Considering the emerging role of TRAIL in ischemia-mediated cell death, this phenomenon may contribute to the protective effects of these small molecules. Our findings support further exploration of PAK and MEK inhibitors as possible agents to avert ischemic kidney injury.

Indexed as

AnimalsButadienesCell HypoxiaCell LineEpithelial CellsHumansMAP Kinase Kinase 1Nitrilesp21-Activated KinasesReceptors, Neurokinin-1RNA InterferenceRNA, Small InterferingSignal TransductionTNF-Related Apoptosis-Inducing LigandButadienesMAP2K1 protein, humanMAP Kinase Kinase 1Nitrilesp21-Activated KinasesPAK1 protein, humanReceptors, Neurokinin-1RNA, Small InterferingTACR1 protein, humanTNF-Related Apoptosis-Inducing LigandU 0126Acute kidney injuryMAP kinase cascadetachykinin receptor 1

Identifiers

PMID30724698
PMCPMC6464575
OpenAlexW2911483228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.